Last updated on December 2019

A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent Adult and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications


Brief description of study

The purpose of this study is to evaluate the clinical and virologic benefit of pimodivir in combination with Standard-of-Care (SOC) treatment compared to placebo in combination with SOC treatment.

Detailed Study Description

This double-blind (neither researchers nor participants know what treatment participant is receiving) study will evaluate efficacy/safety of pimodivir in combination with SOC treatment versus placebo in combination with SOC treatment in adolescent (13 to 17 years), adult (18 to 65 years), and elderly (greater than [>] 65 but less than or equal to [<=] 85 years) non-hospitalized participants with influenza A infection who are at risk of developing complications. The study will be conducted in 3 phases: screening phase, double-blind treatment period (5 days), a post treatment follow-up period (23 days). Study evaluations include efficacy, clinical and virological outcomes, pharmacokinetics (PK), PK/pharmacodynamics, biomarkers, safety and tolerability. The duration of participation in the study for each participant is 28 days.

Clinical Study Identifier: NCT03381196

Find a site near you

Start Over

Engelbrecht, I

Pretoria, South Africa
0.93miles
  Connect »

Emmed Research

Pretoria, South Africa
3.47miles
  Connect »

Into Research

Pretoria, South Africa
3.99miles
  Connect »

Queenswood Clinical Trial Centre

Pretoria, South Africa
5.4miles
  Connect »

Limpopo Clinical Research Initiative

Thabazimbi, South Africa
5.8miles
  Connect »

Jongaie Research

Pretoria, South Africa
5.84miles
  Connect »

Johese Clinical Research

Pretoria, South Africa
9.58miles
  Connect »